InfuSystems Holdings (INFU)
(Delayed Data from AMEX)
$6.56 USD
+0.60 (10.07%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $6.54 -0.02 (-0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.56 USD
+0.60 (10.07%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $6.54 -0.02 (-0.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Smith & Nephew (SNN) Partners InfuSystem for Renasys Edge
by Zacks Equity Research
Smith & Nephew (SNN) inks a three-year agreement with InfuSystem (INFU) to distribute its RENASYS EDGE negative pressure wound therapy system.
Analysts Estimate InfuSystems Holdings, Inc. (INFU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InfuSystems Holdings, Inc. (INFU) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) delivered earnings and revenue surprises of -63.64% and -9.70%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate InfuSystems Holdings, Inc. (INFU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in InfuSystems Holdings, Inc. (INFU): Can Its 14.2% Jump Turn into More Strength?
by Zacks Equity Research
InfuSystems Holdings, Inc. (INFU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.